LIFE SCIENCES & DEEPTECH CAMPUS OF INNOVATION FOR SCIENCES AND INDUSTRY
BOOST positions itself as a transverse Life Sciences and Deep Tech Campus for Sciences and Industry. Addressing key innovation focus areas at the intersection of disciplines such as Pharma/Biotech, TechBio & AI, Quantum, Electronics-Space-Semiconductors as enabling techno to serve the following sub sectors MedTech & Diagnostics, Robotics and Medical Equipment, and also Food & AgriTech, Ageing or Cosmetics.
Boost Campus targets Pharma-Biotech companies developing new compounds, advanced therapeutics (biologics, cell and gene therapies, RNA-based therapies, etc.) or cutting-edge R&D tools. It welcomes start-ups, scale-ups and industrial innovation teams engaged in drug discovery, optimization and preclinical validation of therapeutic candidates. The campus enables strong collaboration with CROs, CDMOs, TechBio players and analytical platforms to accelerate critical stages of therapeutic development. Companies specializing in screening, in silico modeling, biomarker development, process optimization and biomanufacturing benefit from an integrated and flexible environment. With access to wet labs, an in vivo platform, data and GPU computing capacity, and future scalable production units, Boost Campus provides a seamless continuum from translational research to pilot industrialization and scale-up.
Boost Campus can welcome AgriTech and FoodTech companies developing innovative solutions for sustainable, resilient and low-carbon agriculture. This includes start-ups and scale-ups specializing in plant biotechnology, bio-inputs, precision fermentation, alternative proteins, and high-value functional ingredients. The campus can also host players working on health-oriented nutrition, the microbiome, bio-based materials, as well as the optimization of agri-industrial processes through AI and advanced modeling. Companies developing sensors, IoT solutions, agricultural robotics, or analytical technologies for traceability and food safety will also find a supportive environment. By integrating laboratories, data platforms and scalable production capacity, Boost Campus offers a unique continuum from R&D and validation to pilot industrialization and scale-up.
Boost Campus targets companies developing advanced medical equipment for hospitals and healthcare facilities, including medical robotics, imaging systems, surgical assistance devices and exoskeletons. The campus could welcome start-ups, scale-ups and industrial players working on home-based autonomy solutions, integrating smart sensors, connected devices, digital platforms and artificial intelligence. Strong synergies with expertise in electronics, MEMS, semiconductors and data science accelerate design, prototyping, technical testing and functional validation. With access to laboratories, prototyping facilities, data and GPU computing capacity, and future scalable production units, Boost Campus provides an integrated environment to move from proof of concept to pilot industrialization, supporting sustainable and patient-centered healthcare innovation.
Boost Campus can welcome MedTech and Diagnostic companies developing innovative medical devices, in vitro diagnostic (IVD) solutions, medical technologies and equipment integrating advanced electronics, sensors and artificial intelligence. The campus targets start-ups, scale-ups and industrial R&D teams working on monitoring solutions, medical robotics, implantable or connected devices, as well as molecular and digital diagnostic platforms. Strong synergies with DeepTech players (electronics, MEMS, semiconductors, data science, AI) enable accelerated design, prototyping and technical and preclinical validation. With access to laboratories, prototyping spaces, data and GPU computing capacity, and future scalable production units, Boost Campus provides a seamless pathway from proof of concept to pilot industrialization within a flexible multi-tenant environment.
Boost Campus targets TechBio, AI and DeepTech companies developing advanced life-science modeling, AI-driven drug discovery solutions, and high-dimensional biomedical data analytics platforms. It welcomes players specializing in artificial intelligence, machine learning, federated AI technologies, health data cybersecurity and interoperability, as well as companies exploring quantum computing applications for life sciences and industrial process optimization. GPU-as-a-Service providers, sovereign cloud operators and high-performance computing infrastructure companies will find an integrated ecosystem directly connected to the needs of biotech, medtech and industrial stakeholders. With its data center, GPU capacity of up to 15 MW, and strong synergies with wet labs and experimental platforms, Boost Campus enables a seamless continuum between digital simulation, experimental validation and industrial deployment, serving Global Health and life sciences innovation.
Located at the heart of the “Paris – Genopole – Paris-Saclay” Golden Triangle innovation ecosystem, Boost Campus spans a 16-hectare site with direct access to public transport and close proximity to the Massy multimodal hub and Orly Airport. 2026 - Launch. Boost Campus opens 28,000m² of chemistry, biochemistry and pharmacology laboratories, clean rooms, offices, meeting rooms and coworking spaces. End of 2027 - Expansion. An incubator and business center would open, supporting the development of startups and growing companies within the ecosystem. 2028 - Maturity. The campus would reach full scale with a scalable production capacity of 12 units totaling 60,000 m², all designed to provide multi-tenant flexibility and a 4,500 m² data center offering up to 15 MW of GPU computing capacity.
Business acceleration - Investor readiness - Talent scouting, HR and continuing education - Regulatory navigation - Data Science & KOL Management
Explore →
Boost Campus is anchored at the heart of a world-class innovation ecosystem. Its location offers exceptional academic density, with leading universities, top schools and public research institutions in close proximity -including Paris-Saclay, ranked 13th in the Shanghai Ranking, one of the world's most prestigious benchmarks for research excellence. This academic strength is matched by a thriving investment ecosystem. Public funding is available at the regional, national and European levels, while private investment benefits from a dense network of Paris-based VC funds, alongside specialized Life Sciences VC and PE investors creating a fertile environment for innovation and growth.
